Arcosa, Inc. (NYSE:ACA) Shares Purchased by Intech Investment Management LLC

Intech Investment Management LLC raised its stake in Arcosa, Inc. (NYSE:ACAFree Report) by 116.2% in the third quarter, HoldingsChannel reports. The fund owned 10,620 shares of the company’s stock after purchasing an additional 5,707 shares during the period. Intech Investment Management LLC’s holdings in Arcosa were worth $1,006,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also bought and sold shares of ACA. Quadrature Capital Ltd acquired a new position in shares of Arcosa in the 1st quarter valued at $216,000. Price T Rowe Associates Inc. MD raised its position in shares of Arcosa by 4.7% in the first quarter. Price T Rowe Associates Inc. MD now owns 38,999 shares of the company’s stock worth $3,349,000 after acquiring an additional 1,761 shares during the period. Bayesian Capital Management LP purchased a new stake in shares of Arcosa during the 1st quarter worth about $210,000. Boston Partners boosted its stake in shares of Arcosa by 272.6% during the 1st quarter. Boston Partners now owns 220,961 shares of the company’s stock worth $18,947,000 after acquiring an additional 161,662 shares in the last quarter. Finally, Moody National Bank Trust Division grew its position in shares of Arcosa by 4.5% during the 2nd quarter. Moody National Bank Trust Division now owns 12,073 shares of the company’s stock valued at $1,007,000 after acquiring an additional 516 shares during the period. Hedge funds and other institutional investors own 90.66% of the company’s stock.

Arcosa Price Performance

Shares of NYSE ACA opened at $107.37 on Thursday. The firm has a 50-day simple moving average of $97.53 and a 200-day simple moving average of $90.02. The company has a quick ratio of 2.77, a current ratio of 3.61 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $5.24 billion, a price-to-earnings ratio of 41.72 and a beta of 0.71. Arcosa, Inc. has a 52 week low of $72.75 and a 52 week high of $113.43.

Arcosa (NYSE:ACAGet Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.13. Arcosa had a return on equity of 6.64% and a net margin of 5.17%. The company had revenue of $640.40 million for the quarter, compared to analyst estimates of $682.52 million. During the same quarter in the previous year, the company posted $0.73 earnings per share. The firm’s revenue for the quarter was up 8.2% compared to the same quarter last year. On average, equities analysts predict that Arcosa, Inc. will post 3.38 earnings per share for the current fiscal year.

Arcosa Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th were paid a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.19%. The ex-dividend date of this dividend was Tuesday, October 15th. Arcosa’s dividend payout ratio (DPR) is presently 7.60%.

Insider Transactions at Arcosa

In related news, Director Steven J. Demetriou bought 6,000 shares of the firm’s stock in a transaction on Thursday, September 12th. The shares were bought at an average price of $87.70 per share, with a total value of $526,200.00. Following the completion of the transaction, the director now directly owns 9,943 shares of the company’s stock, valued at $872,001.10. This represents a 152.17 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

ACA has been the topic of a number of recent analyst reports. Stephens upgraded Arcosa from an “equal weight” rating to an “overweight” rating and set a $96.00 price target on the stock in a research report on Wednesday, August 7th. Barclays assumed coverage on Arcosa in a research report on Tuesday, October 29th. They set an “overweight” rating and a $106.00 target price on the stock. Finally, Oppenheimer boosted their price target on shares of Arcosa from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Monday, August 19th.

View Our Latest Stock Analysis on ACA

Arcosa Profile

(Free Report)

Arcosa, Inc, together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products.

See Also

Want to see what other hedge funds are holding ACA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arcosa, Inc. (NYSE:ACAFree Report).

Institutional Ownership by Quarter for Arcosa (NYSE:ACA)

Receive News & Ratings for Arcosa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcosa and related companies with MarketBeat.com's FREE daily email newsletter.